Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Source filing unavailable
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $43.10M | $50.31M | $18.53M |
| Net Income | -$8.06M | -$6.83M | -$21.40M |
| EPS Diluted | -$0.22 | -$0.19 | -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
